Erythrocytes as Carriers of Therapeutic Enzymes
نویسندگان
چکیده
منابع مشابه
Proteolytic Enzymes as Therapeutic Targets
treat acquired immunodeficiency syndrome [AIDS]) and against the angiotensin-converting enzyme (ACE) (to treat hypertension) are the only protease inhibitors approved by the FDA for therapeutic use (see Table 1). HIV-1 protease is an aspartic protease that is necessary for the processing of viral polypeptides late in the viral replicative cycle. Inhibition of this activity prevents formation of...
متن کاملErythrocytes as Carrier for Drugs, Enzymes and Peptides
Erythrocytes are potential biocompatible carriers for different drugs, peptide molecules and different enzymes. Now a day the method that is used for encapsulation of pharmaceuticals into the erythrocytes mainly based on the hypo-osmotic dialysis. Encapsulation of these drugs or enzymes or peptides into erythrocytes significantly changes the pharmacokinetic properties of drugs in both animals a...
متن کاملHuman isoprenoid synthase enzymes as therapeutic targets
In the human body, the complex biochemical network known as the mevalonate pathway is responsible for the biosynthesis of all isoprenoids, which consists of a vast array of metabolites that are vital for proper cellular functions. Two key isoprenoids, farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) are responsible for the post-translational prenylation of small GTP-binding ...
متن کاملImmobilized enzymes: crystals or carriers?
The advantages of immobilized over soluble enzymes arise from their enhanced stability and ease of separation from the reaction media, leading to significant savings in enzyme consumption. Immobilization methods range from binding to prefabricated carrier materials to packaging in enzyme crystals or powders. During their use, mass-transfer effects can produce substrate or pH gradients, which re...
متن کاملCarbon nanotubes as cancer therapeutic carriers and mediators
Carbon nanotubes (CNTs) have received increasing attention in biomedical fields because of their unique structures and properties, including high aspect ratios, large surface areas, rich surface chemical functionalities, and size stability on the nanoscale. Particularly, they are attractive as carriers and mediators for cancer therapy. Through appropriate functionalization, CNTs have been used ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmaceutics
سال: 2020
ISSN: 1999-4923
DOI: 10.3390/pharmaceutics12050435